KATHRYN BRUNS: Open Payments
NPI 1467810077 · CELINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 20 payments from 11 companies in 2025. Trend: 2023 $512 · 2024 $192 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Novo Nordisk Inc | 3 | $49 |
| ABBVIE INC. | 3 | $47 |
| Lilly USA, LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Insulet Corporation | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: FARXIGA, REXULTI, QULIPTA, Wegovy, Omnipod, Auvelity, BREZTRI, Ozempic.
Industry payments across OH — which companies pay providers there.
